B. Metzler seel. Sohn & Co. AG Takes Position in Cigna Group $CI

B. Metzler seel. Sohn & Co. AG purchased a new stake in shares of Cigna Group (NYSE:CI - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 35,312 shares of the health services provider's stock, valued at approximately $9,735,000.

Several other large investors have also recently bought and sold shares of the business. Silvant Capital Management LLC purchased a new position in shares of Cigna Group during the 2nd quarter valued at $1,683,000. Mystic Asset Management Inc. purchased a new stake in shares of Cigna Group during the second quarter worth $2,808,000. Portfolio Design Labs LLC acquired a new stake in Cigna Group during the second quarter valued at $425,000. Advisors Capital Management LLC acquired a new stake in Cigna Group during the second quarter valued at $412,000. Finally, PCM Encore LLC purchased a new position in Cigna Group in the second quarter valued at about $651,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 19,436 shares of the firm's stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business's stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 23,012 shares of company stock worth $6,386,550. Company insiders own 0.60% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. UBS Group raised their price target on Cigna Group from $375.00 to $400.00 and gave the stock a "buy" rating in a research note on Friday, May 22nd. Mizuho boosted their price target on Cigna Group from $330.00 to $340.00 and gave the company an "outperform" rating in a research note on Monday, June 8th. Royal Bank Of Canada increased their price objective on Cigna Group from $333.00 to $337.00 and gave the stock an "outperform" rating in a report on Friday, May 1st. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cigna Group in a research report on Monday, June 1st. Finally, Guggenheim lifted their target price on shares of Cigna Group from $338.00 to $361.00 and gave the company a "buy" rating in a research note on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group currently has an average rating of "Moderate Buy" and an average price target of $339.45.

Cigna Group Stock Down 1.1%

CI opened at $274.50 on Friday. The business has a 50 day moving average price of $284.63 and a 200 day moving average price of $281.41. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The firm has a market cap of $72.53 billion, a P/E ratio of 11.36, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts' consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion during the quarter, compared to analysts' expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group's revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the previous year, the company earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts forecast that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group's payout ratio is currently 25.82%.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source